Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Filings indexed 686 across all filing types
Latest filing 2020-04-20 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
2019年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as an announcement of the resolutions from the 2019 Annual General Meeting (AGM) of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting date, attendance, voting results on various proposals including the 2019 annual report, board work report, remuneration plan, audit firm appointment, profit distribution, financial budget, and supervisory board report. The document is primarily focused on the voting results and procedural compliance of the AGM. The document length is 2900 characters, which is relatively short and consistent with an announcement rather than a full report. It does not contain the full annual report or detailed financial statements but rather the official results of shareholder votes at the AGM. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-04-20 Chinese
2020年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2020年第一季度报告' which translates to '2020 First Quarter Report'. It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes. The report covers the first quarter of 2020, with financial data for the period January to March 2020, and comparative data for the same period in 2019. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes unaudited quarterly financial data, management assurances about the report's accuracy, and detailed financial metrics and analysis. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q1 2020
2020-04-16 Chinese
2020年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled '2020年第一季度报告' which translates to '2020 First Quarter Report'. It contains detailed financial data for the first quarter of 2020, including assets, net profit, cash flow, revenue, and expenses. It also includes shareholder information and notes on important matters during the quarter. The document explicitly states it is a quarterly report and includes substantive financial statements and analysis. The length is about 5350 characters, which is sufficient for a quarterly report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2020
2020-04-16 Chinese
2019年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as "无锡祥生医疗科技股份有限公司 2019 年年度股东大会会议资料" which translates to "Wuxi Xiangsheng Medical Technology Co., Ltd. 2019 Annual General Meeting (AGM) Meeting Materials." It contains detailed agenda items for the 2019 AGM, including proposals for the 2019 annual report, board work report, remuneration plans, audit firm appointment, profit distribution, financial reports, and supervisory board work report. The document includes meeting rules, voting procedures, and detailed reports and attachments related to the AGM. The content is consistent with materials typically distributed to shareholders for an AGM, including reports and proposals to be discussed and voted on. It is not the annual report itself but the meeting materials for the AGM where the annual report and other items are presented and voted on. Therefore, the document fits the category of AGM Information (AGM-R). The document length (over 14,000 characters) and detailed content confirm it is the meeting materials, not just an announcement or a brief notice.
2020-04-13 Chinese
2020年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2020 third extraordinary general meeting of shareholders of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting date, attendance, voting results on specific proposals, and legal compliance statements. The content focuses on the voting results and procedural legitimacy of the shareholder meeting rather than presenting financial data, management discussion, or other report types. The document is relatively short (1556 characters) and serves as an official declaration of voting outcomes from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-04-07 Chinese
2020年第三次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2020 third extraordinary general meeting (临时股东大会) of Wuxi Xiangsheng Medical Technology Co., Ltd. It discusses the legality and validity of the meeting's convening, attendance, voting procedures, and results. It is not a financial report, earnings release, or management discussion. It is also not a notice of voting results but a legal opinion supporting the meeting's procedures and outcomes. The document is relatively short (2525 characters) and focuses on legal compliance related to a shareholder meeting. This fits best under Regulatory Filings (RNS) as it is a legal compliance document related to corporate governance and shareholder meeting procedures, not a direct announcement of voting results or a management report.
2020-04-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.